← Leaderboards
Jamin Steffen
Thomas Jefferson University
$137,017
Attributed
$137,017
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53.3K · FY2013–15$100K$75K$50K$25K$0
'13
'14
'15
Funding mix
By agency
NIH$137,017 · 1
By mechanism
F32$137,017 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Jonathan Brody$5,162,616
- Charles M Brenner$6,253,987
- Nathaniel W. Snyder$5,947,517
- Walter John Curran$19,392,586
- Wayne E Childers$697,333
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogAreaAssay DevelopmentBaseBinding (Molecular Function)Binding SitesBiologicalBrca1 GeneCancer CellCancer TherapyCatalytic DomainCell PhysiologyCellsChemotherapyClinical TrialsCommunicationCommunitiesComplexComputer SimulationCost EffectiveCrystallographyDefectDesignAdenosine Diphosphate Ribose
Grant awards (3)
Discovery of new classes of PARP-1 inhibitors for the treatment of cancer$34,521
F32 · FY2015 · CA · contact PI
Discovery of new classes of PARP-1 inhibitors for the treatment of cancer$53,282
F32 · FY2014 · CA · contact PI
Discovery of new classes of PARP-1 inhibitors for the treatment of cancer$49,214
F32 · FY2013 · CA · contact PI